Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FLOT2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | TPT1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | CYBRD1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | KRTAP22-2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | UBN2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | RNF169 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | SLC7A6 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | KCNMB3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | PYURF | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | NPHP4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |